Mesocella-Ortho Administration
Osteoarthritis of Knee
Jagiellonian UniversityCell therapyPhase 1/2Active
CCC
52/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 37/ 100
- Competitive Position
- 95/ 100
Competitive context
30 Active assets in the Osteoarthritis of Knee cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Duloxetine Orthopaedic Arthroscopy Knee and Shoulder Clinic | Phase 4 | BBB |
Naproxen Pfizer | Phase 3 | BB |
TRIAMCINOLONE HEXACETONIDE Kastamonu University | Phase 4 | BB |
DEXAMETHASONE Poznan University of Medical Sciences | Phase 4 | BB |
Oxycodone Riku Antero Palanne | Phase 3 | BB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →